| Year |
Citation |
Score |
| 2016 |
Sell DR, Sun W, Gao X, Strauch C, Lachin JM, Cleary PA, Genuth S, Monnier VM. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes. Cardiovascular Diabetology. 15: 30. PMID 26864236 DOI: 10.1186/S12933-016-0343-3 |
0.553 |
|
| 2015 |
Gubitosi-Klug RA, Sun W, Cleary PA, Braffett BH, Aiello LP, Das A, Tamborlane W, Klein R. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort. Jama Ophthalmology. 1-10. PMID 26584339 DOI: 10.1001/Jamaophthalmol.2015.4606 |
0.726 |
|
| 2015 |
Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S. Erratum to: Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovascular Diabetology. 14: 138. PMID 26453359 DOI: 10.1186/s12933-015-0295-z |
0.604 |
|
| 2015 |
Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovascular Diabetology. 14: 118. PMID 26341632 DOI: 10.1186/S12933-015-0266-4 |
0.579 |
|
| 2015 |
Aiello LP, Sun W, Das A, Gangaputra S, Kiss S, Klein R, Cleary PA, Lachin JM, Nathan DM. Intensive diabetes therapy and ocular surgery in type 1 diabetes. The New England Journal of Medicine. 372: 1722-33. PMID 25923552 DOI: 10.1056/Nejmoa1409463 |
0.709 |
|
| 2015 |
Lachin JM, White NH, Hainsworth DP, Sun W, Cleary PA, Nathan DM. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes. 64: 631-42. PMID 25204977 DOI: 10.2337/Db14-0930 |
0.702 |
|
| 2015 |
Genuth S, Sun W, Cleary P, Gao X, Sell DR, Lachin J, Monnier VM. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes. 64: 266-78. PMID 25187362 DOI: 10.2337/Db14-0215 |
0.675 |
|
| 2015 |
Monnier VM, Sun W, Gao X, Sell DR, Cleary PA, Lachin JM, Genuth S. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes Cardiovascular Diabetology. 14. DOI: 10.1186/s12933-015-0266-4 |
0.604 |
|
| 2014 |
de Boer IH, Afkarian M, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B. Renal outcomes in patients with type 1 diabetes and macroalbuminuria. Journal of the American Society of Nephrology : Jasn. 25: 2342-50. PMID 24925722 DOI: 10.1681/Asn.2013091004 |
0.69 |
|
| 2014 |
Miao F, Chen Z, Genuth S, Paterson A, Zhang L, Wu X, Li SM, Cleary P, Riggs A, Harlan DM, Lorenzi G, Kolterman O, Sun W, Lachin JM, Natarajan R, et al. Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes. 63: 1748-62. PMID 24458354 DOI: 10.2337/Db13-1251 |
0.651 |
|
| 2014 |
de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Zinman B, Steffes MW. Longitudinal changes in estimated and measured GFR in type 1 diabetes. Journal of the American Society of Nephrology : Jasn. 25: 810-8. PMID 24309189 DOI: 10.1681/Asn.2013050557 |
0.58 |
|
| 2014 |
Sun W, Larsen MD, Lachin JM. Methods for a longitudinal quantitative outcome with a multivariate Gaussian distribution multi-dimensionally censored by therapeutic intervention. Statistics in Medicine. 33: 1288-306. PMID 24258796 DOI: 10.1002/Sim.6037 |
0.537 |
|
| 2014 |
Monnier VM, Sun W, Sell DR, Fan X, Nemet I, Genuth S. Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications. Clinical Chemistry and Laboratory Medicine. 52: 21-32. PMID 23787467 DOI: 10.1515/Cclm-2013-0174 |
0.515 |
|
| 2014 |
de Boer I, Sun W, Gao X, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: Long-term follow-up of the diabetes control and complications trial and epidemiology of diabetes interventions and complications study The Lancet Diabetes and Endocrinology. 2: 793-800. DOI: 10.1016/S2213-8587(14)70155-X |
0.719 |
|
| 2013 |
Grassi MA, Sun W, Gangaputra S, Cleary PA, Hubbard L, Lachin JM, Gao X, Kiss S, Barkmeier AJ, Almony A, Davis M, Klein R, Danis RP. Validity of self-report in type 1 diabetic subjects for laser treatment of retinopathy. Ophthalmology. 120: 2580-6. PMID 23890420 DOI: 10.1016/J.Ophtha.2013.06.002 |
0.642 |
|
| 2013 |
Orchard TJ, Sun W, Cleary PA, Genuth SM, Lachin JM, McGee P, Paterson AD, Raskin P, Anbinder Y, Levy AP. Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes. 62: 3218-23. PMID 23761102 DOI: 10.2337/Db13-0256 |
0.685 |
|
| 2013 |
Monnier VM, Sell DR, Strauch C, Sun W, Lachin JM, Cleary PA, Genuth S. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes. Journal of Diabetes and Its Complications. 27: 141-9. PMID 23153673 DOI: 10.1016/J.Jdiacomp.2012.10.004 |
0.666 |
|
| 2012 |
de Boer IH, Sachs MC, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD. Circulating vitamin D metabolites and kidney disease in type 1 diabetes. The Journal of Clinical Endocrinology and Metabolism. 97: 4780-8. PMID 22990096 DOI: 10.1210/Jc.2012-2852 |
0.585 |
|
| 2011 |
de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. The New England Journal of Medicine. 365: 2366-76. PMID 22077236 DOI: 10.1056/Nejmoa1111732 |
0.692 |
|
| 2011 |
Hubbard LD, Sun W, Cleary PA, Danis RP, Hainsworth DP, Peng Q, Susman RA, Aiello LP, Davis MD. Comparison of digital and film grading of diabetic retinopathy severity in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Archives of Ophthalmology (Chicago, Ill. : 1960). 129: 718-26. PMID 21670338 DOI: 10.1001/Archophthalmol.2011.136 |
0.592 |
|
| 2011 |
de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD, White NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Archives of Internal Medicine. 171: 412-20. PMID 21403038 DOI: 10.1001/Archinternmed.2011.16 |
0.704 |
|
| 2011 |
Nathan DM, Steffes MW, Sun W, Rynders GP, Lachin JM. Determining stability of stored samples retrospectively: the validation of glycated albumin. Clinical Chemistry. 57: 286-90. PMID 21030684 DOI: 10.1373/Clinchem.2010.150250 |
0.471 |
|
| 2010 |
Molitch ME, Steffes M, Sun W, Rutledge B, Cleary P, de Boer IH, Zinman B, Lachin J. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care. 33: 1536-43. PMID 20413518 DOI: 10.2337/Dc09-1098 |
0.72 |
|
| 2010 |
White NH, Sun W, Cleary PA, Tamborlane WV, Danis RP, Hainsworth DP, Davis MD. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 59: 1244-53. PMID 20150283 DOI: 10.2337/Db09-1216 |
0.466 |
|
| 2010 |
Kern EF, Erhard P, Sun W, Genuth S, Weiss MF. Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 55: 824-34. PMID 20138413 DOI: 10.1053/J.Ajkd.2009.11.009 |
0.561 |
|
| 2008 |
White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM, Crofford O, Crandall J, Phillips M, Reid M, Brown-Friday J, Engel S, et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial Archives of Ophthalmology. 126: 1707-1715. PMID 19064853 DOI: 10.1001/Archopht.126.12.1707 |
0.715 |
|
| 2008 |
Al-Kateb H, Boright AP, Mirea L, Xie X, Sutradhar R, Mowjoodi A, Bharaj B, Liu M, Bucksa JM, Arends VL, Steffes MW, Cleary PA, Sun W, Lachin JM, Thorner PS, et al. Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study. Diabetes. 57: 218-28. PMID 17914031 DOI: 10.2337/Db07-1059 |
0.661 |
|
| 2006 |
Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes. 55: 3556-65. PMID 17130504 DOI: 10.2337/Db06-0653 |
0.703 |
|
| 2005 |
Genuth S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 54: 3103-11. PMID 16249432 DOI: 10.2337/Diabetes.54.11.3103 |
0.631 |
|
| 1998 |
Yang Z, Wang K, Li T, Sun W, Li Y, Chang YF, Dorman JS, LaPorte RE. Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care. 21: 525-9. PMID 9571336 DOI: 10.2337/Diacare.21.4.525 |
0.405 |
|
| Show low-probability matches. |